Patients with type 1 diabetes are often exposed to healthcare facilities for follow-up visits and prescription refills, and they frequently receive subcutaneous insulin injections [22,23], though the correlation of the subcutaneous insulin injection and MRSA colonization or infection remains unclear. The gene discussed is INS; the disease is infection.